Wissenschaftliches Institut der AOK

What Wissenschaftliches Institut der AOK does

Wissenschaftliches Institut der AOK (WIdO) is a non-profit healthcare research institute founded in 1976 as the scientific arm of AOK, Germany's largest statutory health insurance provider. It is wholly owned and institutionally funded by AOK Bundesverband and operates from offices in Berlin (Rosenthaler Str. 31) and Bonn under Managing Directors Helmut Schröder and Jürgen Klauber. Its core function is to conduct data-driven research on the German statutory health insurance system using routine billing data (Routinedaten) drawn from AOK and the broader GKV system, covering approximately 70 million beneficiaries. It maintains specialized data systems including GKV-HIS and AOK-HIS for therapeutic-services tracking and applies proprietary methodologies such as QSR (Qualitätssicherung mit Routinedaten) for hospital quality measurement — covering 920+ hospitals — and the Kleinräumiges Prognoseverfahren for small-area forecasting used in the regional Gesundheitsatlas covering 401 German districts.

WIdO's principal outputs are approximately twelve annual report series (Buchreihen), including the Heilmittel-Report and Heilmittelbericht (therapeutic supplies), Fehlzeiten-Report (occupational health and absenteeism), Krankenhaus-Report (hospitals), Pflege-Report (nursing care), Arzneimittel-Kompass and Arzneiverordnungs-Report (pharmaceuticals), Qualitätsmonitor (quality monitoring), and Versorgungs-Report (care provision). It also publishes the Ärzteatlas on physician density, two scientific journals (WIdOmonitor and GGW), and collaborates with federal agencies such as Robert Koch-Institut, Umweltbundesamt, and DIVI on joint projects including BURDEN 2020, as well as with numerous German universities including Trier, Rostock, Köln, Hamburg, Bielefeld, and TU Berlin.

WIdO's business model is institutional rather than commercial: it does not sell products to paying customers, does not raise external funding, and does not disclose revenue. Most publications are distributed free of charge as downloads and e-papers; selected annual books are commercially distributed through academic publishers Springer-Verlag and KomPart-Verlag (for example, Heilmittel-Report 2026 priced at €42.79 hardcover). The institute's economic activity therefore consists of AOK Bundesverband institutional funding plus minimal commercial book sales, with no app, API, SaaS, or other recurring-revenue product surface.

Name

Wissenschaftliches Institut der AOK

Legal name

Wissenschaftliches Institut der AOK

Website

https://wido.de

Company type

Private

Founded year

1976

Operating status

Operating

Short description

Wissenschaftliches Institut der AOK (WIdO) is a non-profit German healthcare research institute founded in 1976 that analyzes the statutory health insurance system using AOK routine data covering roughly 70 million beneficiaries, publishing 12+ annual report series for policymakers, federal agencies, and academic researchers.

Ownership category

akta.pro rank

Product category

Healthcare Research and Policy Analysis

NAICS

Scientific Research and Development Services (5417), Professional, Scientific, and Technical Services (54)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)

akta.pro secondary industries

Economic Evaluation & Health Technology Assessment (Public Programs) (HLAJANAL), Notifiable Disease Reporting & Case Investigation (HLAJABAA)

Keywords

• Healthcare research institute
• Health policy analysis
• Statutory health insurance data
• Epidemiological research
• Healthcare quality monitoring

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. AOK System Funding: As the research institute of the AOK (Allgemeine Ortskrankenkasse), WIdO receives institutional funding from the AOK federal association to conduct healthcare research, analyze insurance data, and publish reports on the German health system.
2. Publication Sales: WIdO publishes annual report series (Buchreihen) through external publishers like Springer-Verlag and KomPart-Verlag. Books are sold commercially (e.g., Heilmittel-Report 2026 at €42.79), with some publications available as Open Access.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

WIdO is a non-profit healthcare research institute that analyzes routine billing data from the AOK statutory health insurance system (covering approximately 70 million GKV beneficiaries and ~5 million AOK-insured patients receiving therapeutic services) to produce annual report series, regional health atlases, quality-assurance methodologies, and survey-based publications on the German healthcare system. Its work covers therapeutic services, hospitals, nursing care, pharmaceuticals, occupational health, quality monitoring, and care provision, distributed as printed books, e-papers, journals, and online downloads.

Product overview

WIdO (Wissenschaftliches Institut der AOK) is a healthcare research institute founded in 1976 that conducts research on the German healthcare system. The organization operates primarily as a publisher and research institute rather than a technology product company. Its portfolio consists of annual report series (Buchreihen) covering therapeutic supplies, absenteeism, hospitals, nursing care, pharmaceuticals, quality monitoring, and care provision. These are complemented by journals (WIdOmonitor, GGW), regional health atlases, and quality assurance methodologies using routine data (QSR). WIdO also maintains data systems (GKV-HIS, AOK-HIS) for therapeutic market analysis. The core offering comprises approximately 12 report series plus supporting analytical tools and databases.

Differentiator

Problem solved

Functional benefit

Brands

• WIdOmonitor: A periodical publication by WIdO covering health-related topics and survey results.
• Heilmittel-Report
• Heilmittelbericht
• Fehlzeiten-Report
• Krankenhaus-Report
• Pflege-Report
• Qualitätsmonitor
• Versorgungs-Report
• Gesundheitsatlas

Products and services

• Heilmittel-Report Annual professional publication analyzing therapeutic supplies (Heilmittel) in the German healthcare system, focusing on quality and economic aspects, published jointly with academic partners from Universität Hamburg and BTU Cottbus-Senftenberg.
• Heilmittelbericht Annual analysis of the therapeutic market covering approximately 70 million SHI-insured persons, showing supply trends for four therapeutic areas (ergotherapy, speech therapy, physiotherapy, podology), revenue, and regional utilization.
• Fehlzeiten-Report Annual publication on occupational health management and absenteeism since 1999, providing sick leave statistics across economic sectors and federal states, plus annual representative employee surveys.
• Ärzteatlas Publication analyzing physician density in Germany, presenting current figures on general and specialized outpatient care based on regional data from contractual medical care planning.
• Gesundheitsatlas Regional health atlas providing disease frequency data for 401 districts and independent cities in Germany, covering diabetes, asthma, depression, COPD, and heart attacks using AOK billing data and a specially developed extrapolation method.
• Krankenhaus-Report Annual hospital report analyzing the German hospital sector, reform perspectives, financing, remuneration, care, and structures.
• Pflege-Report Annual report on nursing care and elderly care in Germany, focusing on ensuring care for people in need of care and support.
• Arzneimittel-Kompass Annual publication addressing rising drug expenditures in the German healthcare system and pharmaceutical market dynamics.
• Arzneiverordnungs-Report Annual report analyzing drug prescription patterns and pharmaceutical expenditures of the statutory health insurance system in Germany.
• Qualitätsmonitor Annual publication on healthcare quality monitoring, including quality assurance with routine data (QSR) methodology and hospital quality benchmarking.
• Versorgungs-Report Annual care report covering guidelines, early detection, climate and health, and other healthcare system analyses.
• WIdOmonitor Scientific journal published by WIdO covering health policy topics, employee surveys, and environmental impacts on health.
• GGW - Gesundheit + Gesellschaft Wissenschaft Scientific journal published by WIdO covering health policy and health services research.
• GKV-Heilmittel-Informations-System (GKV-HIS) Information system providing comprehensive data on therapeutic supplies for the statutory health insurance system across four therapy areas (ergotherapy, speech therapy, physiotherapy, podology), serving as the basis for Heilmittelbericht analyses.
• AOK-Heilmittel-Informations-System (AOK-HIS) AOK-specific therapeutic information system used for in-depth analyses requiring insured person linkage, diagnosis, or gender data, covering approximately 5 million AOK-insured patients receiving therapeutic services.
• QSR (Qualitätssicherung mit Routinedaten) Quality assurance methodology using routine insurance billing data to measure and compare treatment quality across hospitals and clinics, including complication rates for procedures like hernia repairs, hip replacements, and knee prosthesis revisions.

Quantifiable outcome

• Analysis of 119.4 million treatment sessions and 14 million prescriptions for therapeutic products in 2024
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Twelve partnerships are on record, tiered minor and core.

• Universität TrierminorStrategic or Co-development Partner · 1 January 2026Collaboration on dementia prevalence projections. WIdO worked with Universität Trier on small-area forecasting methods for predicting dementia cases in Germany through 2060.
• Universität RostockminorStrategic or Co-development Partner · 1 January 2026Collaboration on dementia prevalence projections. WIdO partnered with Universität Rostock for regional health forecasting methodology.
• Universität KölnminorStrategic or Co-development Partner · 1 January 2026Collaboration on dementia prevalence projections. WIdO worked with Universität Köln on epidemiological modeling for dementia case forecasting.
• Universität HamburgcoreStrategic or Co-development Partner · 1 January 2026Prof. Dr. Jonas Schreyögg from Universität Hamburg co-edits the Heilmittel-Report series with WIdO (Helmut Schröder, Andrea Waltersbacher, Nadescha Bachayov), providing academic oversight for therapeutic market analysis.
• Brandenburgische Technische Universität Cottbus – SenftenbergcoreStrategic or Co-development Partner · 1 January 2026Prof. Dr. Christian Kopkow from BTU Cottbus co-edits the Heilmittel-Report 2026, focusing on quality aspects of therapeutic provision in the German healthcare system.
• Universität BielefeldcoreStrategic or Co-development Partner · 1 January 2025Universität Bielefeld co-publishes the annual Fehlzeiten-Report with WIdO, focusing on occupational health management and absenteeism analysis. Prof. Badura leads the collaboration.
• Berliner Hochschule für TechnikcoreStrategic or Co-development Partner · 1 January 2025Berliner Hochschule für Technik co-publishes the Fehlzeiten-Report with WIdO, contributing expertise on occupational health and workplace safety research.
• MCC (Mercator Research Institute on Global Commons and Climate Change)minorStrategic or Co-development Partner · 1 January 2021MCC collaborated with WIdO on the Versorgungs-Report 'Klima und Gesundheit' (2021), analyzing the health impacts of climate change including heat-related hospital admissions.
• Robert Koch-InstitutcoreStrategic or Co-development Partner · 1 January 2020WIdO collaborated with the Robert Koch-Institut on the BURDEN 2020 project, combining WIdO health insurance data with RKI epidemiological expertise for comprehensive disease burden analysis in Germany.
• UmweltbundesamtminorStrategic or Co-development Partner · 1 January 2020WIdO partnered with the German Environment Agency on the BURDEN 2020 project for integrated disease burden calculations incorporating environmental health factors.
• Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)minorStrategic or Co-development Partner · 1 January 2020WIdO collaborated with DIVI and TU Berlin on COVID-19 treatment analysis, combining AOK billing data with ICU registry data to analyze treatment outcomes for hospitalized COVID-19 patients.
• Technische Universität BerlinminorStrategic or Co-development Partner · 1 January 2020TU Berlin contributed statistical expertise to the WIdO-led COVID-19 treatment analysis published in The Lancet Respiratory Medicine, analyzing approximately 10,000 hospitalized patients.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Commonwealth Fund: US foundation focused on healthcare policy research and international health system comparisons. Comparable mission of producing evidence-based health system analyses for policymakers, though with a US/international rather than German SHI focus.
• Bertelsmann Stiftung: Large German private foundation publishing influential healthcare studies (e.g., physician density, hospital structural reform, digital health comparisons). Operates in adjacent health policy research space with similar publication cadence, but as part of a much broader foundation portfolio rather than a dedicated health institute.
• RAND Corporation: US-based policy research organization with substantial health services research, health economics, and quality measurement work. Comparable as an authoritative health policy research voice publishing widely-cited studies, though operating in a different (US) healthcare system context.

Direct peers

• INEK (Institut für das Entgeltsystem im Krankenhaus): German institute responsible for developing and maintaining the G-DRG hospital reimbursement system, deeply embedded in German hospital financing analysis. Comparable to WIdO's Krankenhaus-Report scope, with complementary but more operational focus on DRG calculation.
• WifOR Institute: Darmstadt-based research institute specializing in health economics, social impact measurement, and macroeconomic analyses of health systems. Directly comparable health economics research scope, though smaller and more commercially oriented than WIdO.
• IQTIG (Institut für Qualitätssicherung und Transparenz im Gesundheitswesen): German federal institute for quality assurance and transparency in healthcare, developing quality measurement procedures for hospitals and physician practices. Comparable to WIdO's QSR methodology and hospital quality monitoring work (Qualitätsmonitor), but operates under G-BA mandate.
• IGES Institut: Berlin-based private research and consulting institute focused on health services research, health economics, and health system analysis in Germany. Closest direct peer to WIdO — both produce health system studies and policy-relevant analyses, though IGES operates commercially while WIdO is non-profit.
• IQWiG (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen): Germany's federal health technology assessment (HTA) body, conducting benefit assessments and economic evaluations of medical interventions on behalf of the G-BA. Directly comparable to WIdO's economic evaluation and policy analysis work, with a similar evidence-based mandate but a different institutional sponsor.
• RWI – Leibniz-Institut für Wirtschaftsforschung: German economic research institute with an established health economics department producing reports on hospital financing, sickness fund competition, and SHI system dynamics. Comparable as a German policy research voice but with broader macroeconomic remit than WIdO.

Emerging players

• ZEW – Leibniz-Zentrum für Europäische Wirtschaftsforschung: Mannheim-based economic research institute with health economics and health system research in its portfolio. Comparable as a German policy research producer, though with broader economic remit and less specific focus on SHI claims-data analysis than WIdO.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/wido-werbung

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wissenschaftliches Institut der AOK